European Market Report for Oxygen Therapy Devices 2016 – MedCore
Among Western European countries, France has the largest number of patients on long-term oxygen therapy, and the extensive use of oxygen concentrators is encouraged by some of the highest reimbursement rates in Europe. In contrast, the market for alternative oxygen therapy devices in Italy is well below what population levels, or the number of COPD patients, would suggest. This is largely due to the fact that the reimbursement and regulatory system in Italy is heavily weighted toward the use of liquid oxygen.
- Year: 2016
- Scope: 2012-2022
- Region: Europe
- Published Date: 08/01/2016
- Pages: 80
- Type: MedCore
The regular administration of medical oxygen, also known as oxygen therapy, is used to treat a wide variety of chronic medical conditions, including cancer, cystic fibrosis and chronic obstructive pulmonary disease (COPD). COPD includes chronic obstructive bronchitis and emphysema, and is predicted by the World Health Organization (WHO) to be the fourth leading cause of death worldwide by 2030. In Europe, the prevalence of COPD varies markedly across countries. For example, the Ministère de la Santé et des Solidaritiés estimates that between 6% and 8% of the adult population in France suffers from COPD. In contrast, the Netherlands exhibits only a 2% prevalence rate as estimated by the National Institute for Public Health and the Environment. Generally, these devices are used to treat patients who are no longer able to receive adequate volumes of oxygen through the breathing of natural air and require higher concentrations of oxygen. The number of patients on oxygen therapy is expected to increase significantly as the population ages and as members of the 50 to 75 age demographic, who were often smokers in their youth, develop emphysema and related conditions. It is estimated that 80% to 90% of the patients on oxygen therapy are, or were, once smokers.
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.